EcoDrugPlus

Fyn Proto-Oncogene, Src Family Tyrosine Kinase A

Ensembl ID : ENSCCRG00000006855
Gene Symbol: FYNA
1 Cross references
188 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase A

Ensembl ID : ENSCCRG00000000748
Gene Symbol: FYNA
1 Cross references
189 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase B

Ensembl ID : ENSCCRG00000015327
Gene Symbol: FYNB
1 Cross references
198 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase B

Ensembl ID : ENSCCRG00000056134
Gene Symbol: FYNB
1 Cross references
198 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSCCRG00000056452
Gene Symbol: GPR84
1 Cross references
111 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSCCRG00000035006
Gene Symbol: GPR84
1 Cross references
111 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCCRG00000026958
Gene Symbol: HCK
1 Cross references
200 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCCRG00000024012
Gene Symbol: HCK
1 Cross references
200 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSCCRG00000008658
Gene Symbol: ITK
1 Cross references
204 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSCCRG00000014571
Gene Symbol: ITK
1 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSCCRG00000010632
Gene Symbol: IMPDH1A
1 Cross references
256 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSCCRG00000070872
Gene Symbol: IMPDH1A
1 Cross references
256 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).